Landiolol hydrochloride to successfully treat refractory ventricular arrhythmia during weaning from cardiopulmonary bypass

We effectively treated refractory ventricular arrhythmia (RVA) at the time of weaning from the cardiopulmonary bypass (CPB) during aortic valve replacement with landiolol for three patients who failed to respond to electrical defibrillation. Demographic data, comorbid factors, and preoperative finding were noted [Table 1].

Source: Journal of Clinical Anesthesia - February 27, 2018 Category: Anesthesiology Authors: Mariko Yamada, Shinji Takahashi, Soichiro Yamashita, Makoto Tanaka Tags: Correspondence Source Type: research